| Financial Year |
March 31 2022 |
| Monetary Funds |
11,668,413.08 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
835,950.66 |
| Accounts Receivable |
49,780,643.38 |
| Advances to Suppliers |
51,623,872.33 |
| Other Receivables |
11,959,412.66 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
15,356,868.92 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
2,058.68 |
| Other Current Assets |
22,695,323.78 |
| Total Current Assets |
212,837,797.01 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
-- |
| Investment Properties |
-- |
| Fixed Assetes |
77,537,431.45 |
| Under-construction Projects |
-- |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
45,952.25 |
| R&D expenses |
-- |
| Goodwill |
9,142,173.51 |
| Long-Term Deferred and Prepaid Expenses |
55,598,191.71 |
| Deferred Income Tax Assets |
653,507.74 |
| Other Non-Current Assets |
-- |
| Sub-Total of Non-Current Assets |
149,745,753.39 |
| Total Assets |
362,583,550.40 |
| Short-Term Loans |
-- |
| Trading Financial liabilities |
-- |
| Notes Payable |
-- |
| Accounts Payable |
25,288,023.05 |
| Accounts Received In Advance |
30,817,200.00 |
| Employee Compensation Payable |
2,186,952.91 |
| Taxes Payable |
2,241,220.69 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
29,430,806.25 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
1,747,204.09 |
| Other Current Liabilities |
129,436.60 |
| Sub-Total of Current Liabilities |
94,016,650.88 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
-- |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
5,347,421.79 |
| Total Liabilities |
99,364,072.67 |
| Paid-In Capital(Or Share Stock) |
184,819,607.00 |
| Capital Surplus |
22,820,326.72 |
| Surplus Reserve |
6,885,074.86 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
-61,022,192.01 |
| Minority Stockholder's Interest |
109,716,661.16 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
153,502,816.57 |
| Owner's Equity（Stockholder's Equity） |
263,219,477.73 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
362,583,550.40 |
